Roles
- (Leader) Cystic Fibrosis Group
1. Financial interests
Yes
Please specify
ARS reports grants from Vertex pharmaceuticals paid to his institution (2023).
ARS has previously been part of an advisory board from Viatris Pharmaceuticals honorarium paid to his institution (Jan 2023)
ARS reports membership of the Data Safety Monitoring Board of the Cystic Fibrosis Foundation (personal honorarium paid).
2. Non-financial interests
Yes
Please specify
ARS holds a patent issued “Alkyl quinolones as biomarkers of Pseudomonas aeruginosa infection and uses thereof”.
3. Do you hold any financial or non-financial ties with the Cochrane Collaboration, past or present
No
4. Commercial organisation with an interest in any topic related to health care or medical research
No
